Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the efficacy of PDR001 versus investigator’s choice of chemotherapy in patients with moderately differentiated / undifferentiated locally advanced recurrent or metastatic NPC who progressed on or after first-line therapy
Critère d'inclusion
- Moderately differentiated/undifferentiated locally advanced recurrent or metastatic nasopharyngeal carcinoma